DE69205154T2 - Verwendung von mindestens einem gereinigten peptid, welches durch kaseinhydrolyse hergestellt werden kann und opiataktivität hat, als aktiven bestandteil in der herstellung einer kosmetischen zusammensetzung. - Google Patents

Verwendung von mindestens einem gereinigten peptid, welches durch kaseinhydrolyse hergestellt werden kann und opiataktivität hat, als aktiven bestandteil in der herstellung einer kosmetischen zusammensetzung.

Info

Publication number
DE69205154T2
DE69205154T2 DE69205154T DE69205154T DE69205154T2 DE 69205154 T2 DE69205154 T2 DE 69205154T2 DE 69205154 T DE69205154 T DE 69205154T DE 69205154 T DE69205154 T DE 69205154T DE 69205154 T2 DE69205154 T2 DE 69205154T2
Authority
DE
Germany
Prior art keywords
opiatic
activity
preparation
produced
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69205154T
Other languages
English (en)
Other versions
DE69205154D1 (de
Inventor
Lofti Bitri
Michel Barey
Patrick Darmanton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE69205154D1 publication Critical patent/DE69205154D1/de
Application granted granted Critical
Publication of DE69205154T2 publication Critical patent/DE69205154T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
DE69205154T 1991-03-01 1992-03-02 Verwendung von mindestens einem gereinigten peptid, welches durch kaseinhydrolyse hergestellt werden kann und opiataktivität hat, als aktiven bestandteil in der herstellung einer kosmetischen zusammensetzung. Expired - Lifetime DE69205154T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9102510A FR2673374A1 (fr) 1991-03-01 1991-03-01 Composition cosmetique contenant comme ingredient actif un peptide a activite opiouide.
PCT/FR1992/000191 WO1992015279A1 (fr) 1991-03-01 1992-03-02 Composition cosmetique contenant comme ingredient actif au moins un peptide purifie pouvant etre obtenue par hydrolyse de caseine a activite opioide

Publications (2)

Publication Number Publication Date
DE69205154D1 DE69205154D1 (de) 1995-11-02
DE69205154T2 true DE69205154T2 (de) 1996-05-15

Family

ID=9410265

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69205154T Expired - Lifetime DE69205154T2 (de) 1991-03-01 1992-03-02 Verwendung von mindestens einem gereinigten peptid, welches durch kaseinhydrolyse hergestellt werden kann und opiataktivität hat, als aktiven bestandteil in der herstellung einer kosmetischen zusammensetzung.

Country Status (5)

Country Link
EP (1) EP0573554B1 (de)
DE (1) DE69205154T2 (de)
ES (1) ES2078740T3 (de)
FR (1) FR2673374A1 (de)
WO (1) WO1992015279A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
FR2714390B1 (fr) * 1993-12-23 1996-03-08 Agronomique Inst Nat Rech Procédé d'obtention de produits peptidiques et produits obtenus.
GB0016189D0 (en) * 2000-06-30 2000-08-23 Pepsyn Ltd Cosmetic composition
US6465432B1 (en) * 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
DE10120175A1 (de) * 2001-04-24 2002-10-31 Cognis Deutschland Gmbh Verwendung von Milchproteinhydrolysaten
DE10206353A1 (de) * 2002-02-14 2003-08-28 Cognis Deutschland Gmbh Verwendung von niedermolekularen Proteinhydralysaten
GB0209384D0 (en) 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition
ATE402955T1 (de) * 2002-05-27 2008-08-15 Nestec Sa Säurelösliche proteine aus casein-micellen
JP2007525404A (ja) 2003-08-30 2007-09-06 ネステク ソシエテ アノニム ミセルカゼインの酸可溶性蛋白質
FR2884418B1 (fr) * 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
KR20100056515A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드의 용도
WO2009033810A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
US20100204157A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of a peptide as a therapeutic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3061512A (en) * 1959-06-25 1962-10-30 Borden Co Dermatological preparation
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
KR800001462B1 (ko) * 1979-05-01 1980-12-10 강원명 탈지유로부터 화장품 원료를 제조하는 방법
DE2921216A1 (de) * 1979-05-25 1980-12-04 Teschemacher Hansjoerg Pharmakologisch aktive peptide

Also Published As

Publication number Publication date
FR2673374A1 (fr) 1992-09-04
DE69205154D1 (de) 1995-11-02
ES2078740T3 (es) 1995-12-16
EP0573554B1 (de) 1995-09-27
EP0573554A1 (de) 1993-12-15
FR2673374B1 (de) 1995-01-13
WO1992015279A1 (fr) 1992-09-17

Similar Documents

Publication Publication Date Title
DE69205154T2 (de) Verwendung von mindestens einem gereinigten peptid, welches durch kaseinhydrolyse hergestellt werden kann und opiataktivität hat, als aktiven bestandteil in der herstellung einer kosmetischen zusammensetzung.
CA2251331A1 (en) Calcilytic compounds
KR950700722A (ko) 피부 보호 방법 및 그 조성물(Skin Care Method and Composition)
DE69407419D1 (de) 2' oder 3' -deoxy- und 2' -dideoxy-beta-l-pentafuranonukleoside, verfahren zur herstellung und anwendung in der therapie, insbesondere als antivirale wirkstoffe
TR23040A (tr) Bir siyonopimol tuerevinin fungizit uygulamasi
CA2082505A1 (en) Method of treating alopecia
ES2012580A6 (es) Procedimiento para la produccion de una nueva forma cristalina de ciclosporinas.
CA2139725A1 (en) Endoparasiticidal compositions
RU92016277A (ru) Микробиоциды
SE8700137L (sv) Diuretisk komposition
EP0348184A3 (de) Kosmetisches Präparat
CA2139253A1 (en) Skin external agent
PH27567A (en) Topical compositions
TR23985A (tr) Yeni olan suebstituee merkapto-bis-(1,3,4-oksa-ve tia-diazoller) bunlarin imali ve nematisid ve fungisid terkipler olarak kullanimi
NO941097D0 (no) Hudregenererende kosmetisk preparat
DE69300888T2 (de) Feuchtigkeitsspendende kosmetische Zubereitungen.
DE3687838D1 (de) Deodorant-bettmaterial.
DE20014749U1 (de) Haftcreme mit antibakterieller und zahnplaquehemmender Wirksubstanz für dentale Prothesen
Martin The aftermath of SIDS: Questioning the research
RU97109422A (ru) Сбор, обладающий антидиабетической активностью "челек"
IT9044021A0 (it) Miglioramento degli impasti di ossido di piombo e sostituzione delle griglie di piombo con griglie di fibra di carbonio polverizzata, nonche' di sostituzione delle normali griglie con tessuto di fibra di carbonio.
IT8620815A0 (it) Composizione ad attivita' antirughe e trofiche cutanee.
TH14165A (th) สารกันเสียสำหรับสารผสมตามสูตรที่ใช้ฉีด
FR2709963B1 (fr) Composition dermocosmétique, antifongique, notamment utile dans le traitement de dermites séborréhiques.
TH1912EX (th) ตัวยืด

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR